Curis Inc SEC filings CRIS
Curis Inc has 1,006 filings in SEC EDGAR's recent list, going back to Jun 3, 2005. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 19, 2026 (material agreement, unregistered share sale). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 5, 2025 | Jun 30, 2025 |
| 10-Q | Quarterly report | May 6, 2025 | Mar 31, 2025 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 10-Q | Quarterly report | Aug 1, 2024 | Jun 30, 2024 |
| 10-Q | Quarterly report | May 7, 2024 | Mar 31, 2024 |
| 10-Q | Quarterly report | Nov 2, 2023 | Sep 30, 2023 |
| 10-Q | Quarterly report | Aug 3, 2023 | Jun 30, 2023 |
| 10-Q | Quarterly report | May 4, 2023 | Mar 31, 2023 |
| 10-Q | Quarterly report | Nov 9, 2022 | Sep 30, 2022 |
| 10-Q | Quarterly report | Aug 4, 2022 | Jun 30, 2022 |
| 10-Q | Quarterly report | May 5, 2022 | Mar 31, 2022 |
| 10-Q | Quarterly report | Nov 9, 2021 | Sep 30, 2021 |
| 10-Q | Quarterly report | Aug 3, 2021 | Jun 30, 2021 |
| 10-Q | Quarterly report | May 12, 2021 | Mar 31, 2021 |
| 10-Q | Quarterly report | Nov 10, 2020 | Sep 30, 2020 |
| 10-Q | Quarterly report | Aug 4, 2020 | Jun 30, 2020 |
| 10-Q | Quarterly report | May 12, 2020 | Mar 31, 2020 |
| 10-Q | Quarterly report | Nov 5, 2019 | Sep 30, 2019 |
| 10-Q | Quarterly report | Aug 9, 2019 | Jun 30, 2019 |
| 10-Q | Quarterly report | May 14, 2019 | Mar 31, 2019 |
| 10-Q | Quarterly report | Nov 1, 2018 | Sep 30, 2018 |
| 10-Q | Quarterly report | Aug 2, 2018 | Jun 30, 2018 |
| 10-Q | Quarterly report | May 3, 2018 | Mar 31, 2018 |
| 10-Q | Quarterly report | Nov 7, 2017 | Sep 30, 2017 |
| 10-Q | Quarterly report | Aug 3, 2017 | Jun 30, 2017 |
| 10-Q | Quarterly report | May 4, 2017 | Mar 31, 2017 |
| 10-Q | Quarterly report | Nov 3, 2016 | Sep 30, 2016 |
| 10-Q | Quarterly report | Aug 4, 2016 | Jun 30, 2016 |
| 10-Q | Quarterly report | May 9, 2016 | Mar 31, 2016 |
| 10-Q | Quarterly report | Nov 9, 2015 | Sep 30, 2015 |
| 10-Q | Quarterly report | Aug 6, 2015 | Jun 30, 2015 |
| 10-Q | Quarterly report | May 7, 2015 | Mar 31, 2015 |
| 10-Q | Quarterly report | Nov 10, 2014 | Sep 30, 2014 |
| 10-Q | Quarterly report | Aug 7, 2014 | Jun 30, 2014 |
| 10-Q | Quarterly report | May 9, 2014 | Mar 31, 2014 |
| 10-Q | Quarterly report | Nov 12, 2013 | Sep 30, 2013 |
| 10-Q | Quarterly report | Aug 8, 2013 | Jun 30, 2013 |
| 10-Q | Quarterly report | May 9, 2013 | Mar 31, 2013 |
| 10-Q | Quarterly report | Nov 6, 2012 | Sep 30, 2012 |
| 10-Q | Quarterly report | Aug 9, 2012 | Jun 30, 2012 |
| 10-Q | Quarterly report | May 10, 2012 | Mar 31, 2012 |
| 10-Q | Quarterly report | Oct 31, 2011 | Sep 30, 2011 |
| 10-Q | Quarterly report | Aug 4, 2011 | Jun 30, 2011 |
| 10-Q | Quarterly report | Apr 28, 2011 | Mar 31, 2011 |
| 10-Q | Quarterly report | Oct 28, 2010 | Sep 30, 2010 |
| 10-Q/A | Amended quarterly report | Aug 4, 2010 | Jun 30, 2010 |
| 10-Q | Quarterly report | Aug 3, 2010 | Jun 30, 2010 |
| 10-Q | Quarterly report | May 6, 2010 | Mar 31, 2010 |
| 10-Q | Quarterly report | Oct 29, 2009 | Sep 30, 2009 |
| 10-Q | Quarterly report | Jul 30, 2009 | Jun 30, 2009 |
| 10-Q | Quarterly report | May 5, 2009 | Mar 31, 2009 |
| 10-Q | Quarterly report | Oct 28, 2008 | Sep 30, 2008 |
| 10-Q | Quarterly report | Jul 30, 2008 | Jun 30, 2008 |
| 10-Q | Quarterly report | Apr 30, 2008 | Mar 31, 2008 |
| 10-Q | Quarterly report | Oct 30, 2007 | Sep 30, 2007 |
| 10-Q | Quarterly report | Jul 31, 2007 | Jun 30, 2007 |
| 10-Q | Quarterly report | May 2, 2007 | Mar 31, 2007 |
| 10-Q | Quarterly report | Nov 9, 2006 | Sep 30, 2006 |
| 10-Q | Quarterly report | Jul 28, 2006 | Jun 30, 2006 |
| 10-Q | Quarterly report | May 10, 2006 | Mar 31, 2006 |
| 10-Q/A | Amended quarterly report | Mar 31, 2006 | Sep 30, 2005 |
| 10-Q/A | Amended quarterly report | Mar 31, 2006 | Jun 30, 2005 |
| 10-Q/A | Amended quarterly report | Mar 31, 2006 | Mar 31, 2005 |
| 10-Q | Quarterly report | Nov 14, 2005 | Sep 30, 2005 |
| 10-Q | Quarterly report | Aug 9, 2005 | Jun 30, 2005 |
Showing 68 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CRIS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Lexington, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1108205
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.